Posted by Michael Wonder on 31 Jul 2019
Eli Lilly CEO to 2020 candidates: capping drug prices would not lead to lower health care costs
30 July 2019 - Democratic proposals aimed at lowering health-care costs target Big Pharma directly.
Eli Lilly CEO David Ricks told CNBC on Tuesday that prescription drug costs would still soar even if Democrats managed to cap the prices that pharmaceutical companies are allowed to charge.
“There’s a lot of rhetoric in the air, and most of it non-productive,” Ricks told with “Squawk Box. ”
“We could cap that forever. And what we get is less innovation and still have growing health-care costs.”
